The Genome Editing Congress 2015 will have over 400 delegates representing internationally renowned research & academic institutions, clinical research institutions, as well as leading pharmaceutical and biotech companies. There will be over 20 presentations dedicated to genome editing technologies such as CRISPR, TALENs and ZLNs as well as the applications of genome editing in cardiovascular diseases, genetic disorders and immunotherapies.
There will also be over 60 further presentations focusing on the therapeutic application of next generation sequencing technologies, transferring NGS into the clinic, single cell ‘omics, single cell analysis technologies.
Including 2 interactive streams:
Therapeutic Applications of Genome Editing
Genome Editing Techniques
It will be co-located with Europe’s most established 7th Annual Next Generation Sequencing Congress & 3rd Annual Single Cell Analysis Congress.